FILTER
FILTERED ARTICLE RESULTS
Safety First
April 03, 2018
Optimizing inspection, testing and maintenance measures are a crucial aspect of Canada’s aerospace industry.
Saskatchewan’s Mining Industry: Converting Potential into Success
January 31, 2018
Ranked the top destination for mineral exploration investment by the Fraser Institute in 2016, Saskatchewan has held strong ties to the mining sector for many years.
Building Foundations: Manitoba’s Mining Renaissance
January 09, 2018
Despite a gap between industry size and apparent attractiveness, Manitoba has the makings for long-term success.
Driving Efficiency to Increase Competitiveness: Québec’s Service and Equipment Providers
November 10, 2017
With high proficiency in innovative technologies and ...
The Big Four and the Competitiveness of Québec’s Aerospace Supply Chain
September 28, 2017
Supported by the broader ecosystem with an increasing emphasis on collaboration, Québec’s OEMs continue to drive the region’s aerospace industry through economic impact and access to global markets.
Banding Together: Québec’s Innovation Ecosystem
September 05, 2017
Québec’s aerospace industry is a prime example of the benefits of collaboration in driving innovation .
Aerospace in Québec: The Case for an Industrial Policy
August 02, 2017
A proper aerospace industrial policy is needed to ensure the industry’s future success.
Vancouver Leads North America’s Exploration Revival
July 14, 2017
In Mexico, Alaska and mainland USA, Vancouver companies are leading the exploration revival.
A New Order: Québec’s Supply Chain Reaches Turning Point
June 28, 2017
Are pressures to integrate causing a fundamental change in the market structure of Québec’s aerospace supply chain?
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
